Skip to Main content Skip to Navigation
New interface
Journal articles

Negative regulation of type I interferon signaling: facts and mechanisms.

Abstract : Initially described for their antiviral activities, type I Interferons are now recognized as central regulatory elements of the immune response, primarily for their effect on the differentiation of monocytes into dendritic cells and osteoclasts. They are routinely used in clinic for the treatment of several diseases, including viral hepatitis, multiple sclerosis and several forms of cancer. Interferons are however not devoid of toxic effects when high doses are administered to patients, indicating that interferon action must be timely and spatially down regulated. We review here the molecular mechanisms which have been described to shut off the interferon initiated signals.
Document type :
Journal articles
Complete list of metadata
Contributor : Bérengère Hugot Connect in order to contact the contributor
Submitted on : Wednesday, July 11, 2007 - 10:39:58 AM
Last modification on : Thursday, October 13, 2022 - 8:26:02 AM


  • HAL Id : pasteur-00161598, version 1
  • PUBMED : 16914099



E.M. Coccia, Sandra Pellegrini, Gilles Uzé. Negative regulation of type I interferon signaling: facts and mechanisms.. Cellular and Molecular Biology, 2006, 52(1), pp.77-87. ⟨pasteur-00161598⟩



Record views